Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1267, 2000-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Is early intervention with biological agents worthwhile in RA?
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
Access to resources
Recommend
Are full or modified HAQ QOL questionnaires best in RA?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. :
Rofecoxib: an alternative to naproxen in juvenile RA?
Inpharma, Vol. 1, Iss. 1419, 2004-01 ,pp. :
Folate supplementation + methotrexate worthwhile in RA?
Inpharma, Vol. 1, Iss. 1447, 2004-01 ,pp. :
Infliximab + methotrexate: the BeST induction therapy for early RA?
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :